Copyright
©The Author(s) 2017.
World J Gastroenterol. Sep 28, 2017; 23(36): 6685-6693
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6685
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6685
Variable | Disease-free survival | Overall survival | ||||||
5-yr survival | Univariate analysis | Multivariate analysis | 5-yr survival | Univariate analysis | Multivariate analysis | |||
P value | HR (95%CI) | P value | P value | HR (95%CI) | P value | |||
Gender | 0.682 | 0.965 | ||||||
Male | 13 (18.8) | 14 (20.3) | ||||||
Female | 10 (16.4) | 10 (16.4) | ||||||
Age (yr) | 0.039 | 1.291 (0.680-2.453) | 0.435 | 0.230 | ||||
< 65 | 19 (19.2) | 20 (20.2) | ||||||
> 65 | 4 (12.9) | 4 (12.9) | ||||||
CA19-9 | 0.287 | 0.301 | ||||||
< 200 | 13 (23.2) | 14 (25) | ||||||
> 200 | 10 (13.5) | 10 (13.5) | ||||||
ALB (g/L) | 0.005 | 0.669 (0.413-1.085) | 0.103 | 0.009 | 0.760 (0.492-1.173) | 0.215 | ||
< 35 | 3 (7.1) | 3 (7.1) | ||||||
> 35 | 21 (23.9) | 20 (22.7) | ||||||
Surgical method | 0.847 | 0.684 | ||||||
Left-sided hepatectomy | 13 (15.1) | 13 (15.1) | ||||||
Right-sided hepatectomy | 10 (17.2) | 11 (19.0) | ||||||
Resection margin | < 0.001 | 6.255 (3.485-11.229) | < 0.001 | < 0.001 | 6.776 (3.988-11.479) | < 0.001 | ||
Positive | 0 | 0 | ||||||
Negative | 23 (23.7) | 24 (24.7) | ||||||
Histologic grade | 0.023 | 1.594 (0.994-2.554) | 0.053 | 0.026 | 1.294 (0.830-2.017) | 0.256 | ||
Well/moderate | 20 (21.5) | 21 (22.6) | ||||||
poor | 3 (8.1) | |||||||
Perineural invasion | 0.211 | 0.417 | ||||||
Present | 14 (22.6) | 15 (24.2) | ||||||
Absent | 9 (13.2) | 9 (13.2) | ||||||
T stage | 0.004 | 1.582 (0.390-6.415) | 0.521 | 0.001 | 2.399 (0.734-7.836) | 0.147 | ||
T1/2 | 22 (22) | 21 (21) | ||||||
T3/4 | 2 (6.7) | 2 (6.7) | ||||||
N stage | < 0.001 | 2.902 (1.132-7.439) | 0.027 | < 0.001 | 2.827 (1.243-6.429) | 0.013 | ||
N0 | 22 (27.2) | 23 (28.4) | ||||||
N1 | 1 (2.0) | 1 (2.0) | ||||||
AJCC stage | < 0.001 | 0.673 (0.289-1.567) | 0.358 | < 0.001 | 0.844 (0.351-2.028) | 0.704 | ||
Stage I/II | 20 (32.8) | 21 (34.4) | ||||||
Stage III/IV | 3 (4.9) | 3 (4.9) | ||||||
Lymphovascular invasion | < 0.001 | 2.799 (1.588-4.935) | < 0.001 | < 0.001 | 2.908 (1.712-4.938) | < 0.001 | ||
Present | 0 | 0.000 | ||||||
Absent | 23 (22.8) | 24 (24.8) | ||||||
Tumor size (mm) | < 0.001 | 1.942 (1.176-3.209) | 0.010 | < 0.001 | 1.739 (1.101-2.745) | 0.018 | ||
≤ 30 | 15 (20) | 16 (21.3) | ||||||
> 30 | 8 (14.5) | 8 (14.5) | ||||||
Portal vein invasion | 0.003 | 1.759 (0.534-5.800) | 0.353 | 0.002 | 1.130 (0.408-3.127) | 0.815 | ||
Present | 1 (4.2) | 1 (4.2) | ||||||
Absent | 22 (20.8) | 23 (21.7) | ||||||
Hepatic invasion | 0.008 | 1.499 (0.612-3.668) | 0.376 | 0.013 | 1.196 (0.526-2.719) | 0.669 | ||
Present | 1 (9.1) | 1 (9.1) | 1 (9.1) | |||||
Absent | 22 (18.5) | 22 (18.5) | 23 (19.3) | |||||
Transfusion | 0.445 | 0.199 | ||||||
Yes | 11 (16.4) | 11 (16.4) | ||||||
No | 12 (19.0) | 13 (20.6) |
- Citation: Li B, Xiong XZ, Zhou Y, Wu SJ, You Z, Lu J, Cheng NS. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma. World J Gastroenterol 2017; 23(36): 6685-6693
- URL: https://www.wjgnet.com/1007-9327/full/v23/i36/6685.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i36.6685